HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaoru Kiguchi Selected Research

Kaoru Kiguchi Research Topics

Disease

22Neoplasms (Cancer)
06/2015 - 03/2002
12Carcinogenesis
06/2015 - 05/2002
4Hyperplasia
11/2014 - 03/2002
4Carcinoma (Carcinomatosis)
07/2012 - 08/2005
3Breast Neoplasms (Breast Cancer)
12/2012 - 09/2008
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2012 - 08/2004
2Biliary Tract Neoplasms (Biliary Tract Cancer)
06/2015 - 06/2007
2Inflammation (Inflammations)
11/2012 - 08/2008
2Gallbladder Neoplasms (Gallbladder Cancer)
06/2007 - 04/2007
1Adenocarcinoma
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2011
1Skin Neoplasms (Skin Cancer)
09/2008
1Pancreatic Diseases (Pancreatic Disease)
08/2008
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2006
1Neoplasm Metastasis (Metastasis)
08/2004
1Papilloma (Papillomatosis)
04/2004
1Alopecia (Baldness)
05/2002

Drug/Important Bio-Agent (IBA)

9ErbB Receptors (EGF Receptor)IBA
06/2015 - 04/2004
4Proteins (Proteins, Gene)FDA Link
11/2012 - 06/2007
3Phosphotransferases (Kinase)IBA
06/2014 - 01/2006
3GemcitabineFDA Link
08/2012 - 05/2011
3Therapeutic UsesIBA
07/2012 - 04/2007
3DNA (Deoxyribonucleic Acid)IBA
04/2012 - 09/2004
3CarcinogensIBA
01/2009 - 03/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2008 - 05/2002
2Bile Acids and Salts (Bile Acids)IBA
06/2015 - 06/2014
2Sirolimus (Rapamycin)FDA Link
11/2014 - 04/2007
2Epidermal Growth Factor (EGF)IBA
04/2012 - 01/2012
2Tyrosine Kinase InhibitorsIBA
08/2010 - 08/2005
2Phorbol EstersIBA
10/2009 - 03/2002
29,10-Dimethyl-1,2-benzanthraceneIBA
10/2009 - 04/2004
2Biomarkers (Surrogate Marker)IBA
09/2008 - 08/2008
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2007 - 05/2002
2TOR Serine-Threonine KinasesIBA
04/2007 - 04/2006
1Biological ProductsIBA
02/2015
1Mechanistic Target of Rapamycin Complex 1IBA
11/2014
1Tyrosine (L-Tyrosine)FDA Link
06/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
12/2012
1Prostaglandins EIBA
12/2012
1Insulin (Novolin)FDA Link
12/2012
1Small Interfering RNA (siRNA)IBA
08/2012
1PolyethyleneimineIBA
08/2012
1DeoxycytidineIBA
08/2012
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
08/2012
1MicroRNAs (MicroRNA)IBA
07/2012
1abexinostatIBA
07/2012
1Histone Deacetylase InhibitorsIBA
07/2012
1Liposomes (Liposome)IBA
04/2012
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
04/2012
1Polyethylene (Polythene)IBA
04/2012
1LigandsIBA
01/2012
1polyethylene glycol 2000IBA
05/2011
1GW2974IBA
08/2010
1tyrosine receptor (receptor, tyrosine)IBA
08/2010
1Codon (Codons)IBA
10/2009
1Transforming Growth Factor-beta Type II ReceptorIBA
02/2009
1NF-kappa B (NF-kB)IBA
02/2009
1Keratins (Keratin)IBA
09/2008
1Phenobarbital (Luminal)FDA Link
09/2008
1Keratin-5 (Keratin 5)IBA
09/2008
1Activating Transcription Factor 3IBA
09/2008
1Basic-Leucine Zipper Transcription FactorsIBA
09/2008
1Messenger RNA (mRNA)IBA
06/2007
1apricoxibIBA
06/2007
1MacrolidesIBA
04/2007
1GTP Phosphohydrolases (GTPases)IBA
04/2006
1Tuberous Sclerosis Complex 1 ProteinIBA
04/2006
1Tuberous Sclerosis Complex 2 ProteinIBA
04/2006
1Gefitinib (Iressa)FDA Link
08/2005
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2004
1src-Family KinasesIBA
08/2004
1Mifepristone (RU 486)FDA Link
08/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2004
1Keratin-14 (Keratin 14)IBA
05/2002
1EnzymesIBA
05/2002
1ProstaglandinsIBA
05/2002
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2002
1CSK Tyrosine-Protein KinaseIBA
03/2002

Therapy/Procedure

4Therapeutics
04/2012 - 09/2004
1Aftercare (After-Treatment)
08/2004